Redefining schizophrenia treatment with muscarinic modulation-A perspective.

Eur Neuropsychopharmacol

Department of Psychiatry, Student of Medicine, King Edward Medical University, Lahore, Pakistan. Electronic address:

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2024.11.014DOI Listing

Publication Analysis

Top Keywords

redefining schizophrenia
4
schizophrenia treatment
4
treatment muscarinic
4
muscarinic modulation-a
4
modulation-a perspective
4
redefining
1
treatment
1
muscarinic
1
modulation-a
1
perspective
1

Similar Publications

Redefining schizophrenia treatment with muscarinic modulation-A perspective.

Eur Neuropsychopharmacol

December 2024

Department of Psychiatry, Student of Medicine, King Edward Medical University, Lahore, Pakistan. Electronic address:

View Article and Find Full Text PDF

Antipsychotic medications are essential when treating schizophrenia spectrum and other psychotic disorders, but the efficacy and tolerability of these medications vary from person to person. This interindividual variation is likely mediated, at least in part, by epigenomic processes that have yet to be fully elucidated. Herein, we systematically identified and evaluated 65 studies that examine the influence of antipsychotic drugs on epigenomic changes, including global methylation (9 studies), genome-wide methylation (22 studies), candidate gene methylation (16 studies), and histone modification (18 studies).

View Article and Find Full Text PDF
Article Synopsis
  • Neuroimaging databases for neuro-psychiatric disorders provide valuable data for researchers to explore diseases, develop machine learning models, and redefine understanding of these conditions.* ! -
  • A review identified 42 global MRI datasets totaling 23,293 samples from patients with various disorders, including mood, developmental, schizophrenia, Parkinson's, and dementia.* ! -
  • Improved governance and addressing technical issues of these databases are essential for sharing data across borders, aiding in understanding, diagnosing, and creating early interventions for neuro-psychiatric disorders.* !
View Article and Find Full Text PDF
Article Synopsis
  • This study used machine learning to classify subtypes of schizophrenia by analyzing brain images from over 4,000 patients and healthy individuals through international collaboration.* -
  • Researchers identified two neurostructural subgroups: one with predominant cortical loss and enlarged striatum, and another with significant subcortical loss in areas like the hippocampus and striatum.* -
  • The findings suggest this new imaging-based classification could redefine schizophrenia based on biological similarities, enhancing our understanding and treatment of the disorder.*
View Article and Find Full Text PDF

Background: Diagnostic criteria for mental disorders are subject to change. This is particularly true for schizophrenia, whose diagnostic criteria in the current DSM-5 bear little resemblance to what Kraepelin once named "dementia praecox" and Bleuler termed "the schizophrenias." The present study reports results from a survey of experts on two core topics of schizophrenia: (a) whether subsequent editions of the DSM should once again give the Schneiderian first-rank symptoms (FRS; eg, thought broadcasting) the prominent role they had in the DSM-IV and (b) whether the currently quite narrow definition of hallucinations in the DSM-5 requiring them to be vivid and clear and have the full force and impact of normal perceptions should be broadened to incorporate perceptual-like phenomena that the individual can differentiate from proper perceptions but still perceives as real and externally generated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!